Xie Xiangyang, Yang Yanfang, Yang Yang, Zhang Hui, Li Ying, Mei Xingguo
a Beijing Institute of Pharmacology and Toxicology , Beijing , China.
b Wuhan General Hospital of Guangzhou Military Command , Wuhan , China , and.
Drug Deliv. 2016 Sep;23(7):2445-2456. doi: 10.3109/10717544.2015.1008707. Epub 2015 Feb 19.
The conjugation of tunable peptides or materials with nanocarriers represents a promising approach for drug delivery to tumor cells. In this study, we report the development of a novel liposomal carrier system that exploits the cell surface binding synergism between photo-sensitive peptides (PSPs) and targeting ligands. The positive charges of the lysine residues on the cell-penetrating peptides (CPPs) were temporarily caged by the photolabile-protective groups (PG), thereby forming a PSP. Furthermore, this PSP enhances specific uptake into cancer cells after rapidly uncaging the PG via near-infrared (NIR) light illumination. In the circulatory system, the cell penetrability of PSP was hindered. In contrast, the asparagine-glycine-arginine (NGR) peptide moieties, selectively bind to CD13-positive tumors, were attached to the nanocarrier to facilitate the active accumulation of this liposomal carrier in tumor tissue. The dual-modified liposomes (PSP/NGR-L) were prepared by emulsification method, and the concentrations of DSPE-PEG-psCPP and DSPE-PEG-NGR in the liposomes were chosen to be 4% and 1% (molar ratio), respectively. The mean particle size of the PSP/NGR-L was about 95 nm, and the drug entrapment efficiency was more than 90%. Cellular uptake results demonstrated that the proposed PSP/NGR-L had an enhancement of cancer cell recognition and specific uptake. Furthermore, the PSP/NGR-L demonstrated a stronger antitumor efficacy in the HT-1080 tumor model in nude mice with the aid of NIR illumination.
可调节肽或材料与纳米载体的缀合是一种有前景的肿瘤细胞给药方法。在本研究中,我们报道了一种新型脂质体载体系统的开发,该系统利用了光敏肽(PSP)与靶向配体之间的细胞表面结合协同作用。细胞穿透肽(CPP)上赖氨酸残基的正电荷被光不稳定保护基团(PG)暂时封闭,从而形成PSP。此外,通过近红外(NIR)光照快速解开PG后,这种PSP增强了对癌细胞的特异性摄取。在循环系统中,PSP的细胞穿透性受到阻碍。相比之下,选择性结合CD13阳性肿瘤的天冬酰胺-甘氨酸-精氨酸(NGR)肽部分连接到纳米载体上,以促进这种脂质体载体在肿瘤组织中的主动积累。通过乳化法制备了双修饰脂质体(PSP/NGR-L),脂质体中DSPE-PEG-psCPP和DSPE-PEG-NGR的浓度分别选择为4%和1%(摩尔比)。PSP/NGR-L的平均粒径约为95nm,药物包封率超过90%。细胞摄取结果表明,所提出的PSP/NGR-L增强了癌细胞识别和特异性摄取。此外,在近红外光照的帮助下,PSP/NGR-L在裸鼠的HT-1080肿瘤模型中表现出更强的抗肿瘤功效。